Arcus Biosciences Inc (RCUS) support and resistance · rev $58.0M
Arcus Biosciences Inc (RCUS) is a biotechnology company listed on US.
This page maps Arcus Biosciences Inc (RCUS) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported RCUS revenue for 2026-06-30 was $58.0M. Net income was -$219.0M. RCUS currently screens at market cap $885.2M.
RCUS currently screens at market cap $885.2M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new RCUS 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the RCUS quote page for the session range and the stock page for the full model.
Not investment advice.